Entering text into the input field will update the search result below

Accenture CEO Nanterme diagnosed with colon cancer, has had surgery

Jul. 06, 2016 7:19 PM ETAccenture plc (ACN) StockACNBy: Jason Aycock, SA News Editor3 Comments
  • Accenture (NYSE:ACN) says its CEO Pierre Nanterme has been diagnosed with colon cancer, and is now recovering from surgery.
  • He'll still be actively involved in day-to-day operations, he says in a company 8-K.
  • "I am pleased to report that I have already had surgery, which went very well," Nanterme writes in a letter to colleages, clients and shareholders. "I will now move to the next phase of my treatment. I have been advised by my doctors that I will be able to stay actively involved in the day-to-day operations of the company throughout this process. I will, however, reduce my travel during the treatment period, which is expected to be a few months."
  • Nanterme has been CEO since 2011; he joined the company in 1983.

Recommended For You

About ACN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ACN--
Accenture plc